Skip to main content

MARIMED INC

For the period ended Dec 31, 2023. Filed Mar 7, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Mar 7, 2024

MRMDStored price and day change unavailable

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Table of Contents

Page
Part I
Item 1Business2
Item 1ARisk Factors7
Item 1BUnresolved Staff Comments18
Item 1CCybersecurity18
Item 2Properties19
Item 3Legal Proceedings20
Item 4Mine Safety Disclosures21
Part II
Item 5Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities22
Item 6Reserved22
Item 7Management’s Discussion and Analysis of Financial Condition and Results of Operations22
Item 7AQuantitative and Qualitative Disclosures About Market Risk32
Item 8Financial Statements and Supplementary Data33
Item 9Changes in and Disagreements with Accountants on Accounting and Financial Disclosure73
Item 9AControls and Procedures73
Item 9BOther Information74
Item 9CDisclosure Regarding Foreign Jurisdictions that Prevent Inspection74
Part III
Item 10Directors, Executive Officers and Corporate Governance75
Item 11Executive Compensation75
Item 12Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters75
Item 13Certain Relationships and Related Transactions, and Director Independence75
Item 14Principal Accountant Fees and Services75
Part IV
Item 15Exhibits and Financial Statement Schedules76
Signatures81

CAUTIONARY STATEMENT REGARDING FORWARD LOOKING INFORMATION

This Annual Report on Form 10-K includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934 as amended. These statements involve risks and uncertainties, and our actual results could differ significantly from those discussed herein. These include statements about our expectations, beliefs, intentions or strategies for the future, which the Company indicates by words or phrases such as “anticipate,” “expect,” “estimate,” “could,” “should,” “would,” “project,” “predict,” “intend,” “plan,” “will,” “believe,” and similar language, including those set forth in the discussion under “Description of Business,” “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” as well as those discussed elsewhere in this Annual Report on Form 10-K. The Company bases its forward-looking statements on information currently available to it, and the Company believes that the assumption and expectations reflected in such forward-looking statements are reasonable. The Company assumes no obligation to revise or update any revision to these forward-looking statements, except as required by law. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. Statements contained in this Form 10-K that are not historical facts are forward-looking statements that are subject to the “safe harbor” created by the Private Securities Litigation Reform Act of 1995.

Unless expressly indicated or the context requires otherwise, the terms "MariMed", "company", "we", "us", "our", and "Company" in this document refer to MariMed Inc., a Delaware corporation, and, where appropriate, its subsidiaries.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.